Cargando…
JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer*
Amplification and overexpression of c-Myc is commonly seen in human ovarian cancers, and this could be a potentially novel therapeutic target for this disease. JQ1, a selective small-molecule BET bromodomain (BRDs) inhibitor, has been found to suppress tumor progression in several cancer cell types....
Autores principales: | Qiu, Haifeng, Jackson, Amanda L., Kilgore, Joshua E., Zhong, Yan, Chan, Leo Li-Ying, Gehrig, Paola A., Zhou, Chunxiao, Bae-Jump, Victoria L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466659/ https://www.ncbi.nlm.nih.gov/pubmed/25762632 |
Ejemplares similares
-
JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer
por: Qiu, Haifeng, et al.
Publicado: (2016) -
NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo
por: Zhang, Lu, et al.
Publicado: (2016) -
Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer
por: Jackson, Amanda L., et al.
Publicado: (2017) -
Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer
por: Guo, Hui, et al.
Publicado: (2016) -
The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer
por: Suri, Anuj, et al.
Publicado: (2016)